The vanishing bile duct syndrome in a child with Hodgkin disease.
Ozkan
A
A
Department of Pediatric Hematology-Oncology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey. alpozkan74@hotmail.com
Yoruk
A
A
Celkan
T
T
Apak
H
H
Yildiz
I
I
Ozbay
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001649:Bile Duct Diseases / Q000209:etiology*; D001761:Bleomycin / Q000008:administration & dosage; D002675:Child, Preschool; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007565:Jaundice / Q000209:etiology; D008297:Male; D013577:Syndrome; D014747:Vinblastine / Q000008:administration & dosage
D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin